About
Christoph Lengauer is the co-founder and Chief Scientific Officer of Curie.Bio, where he supports founders launching therapeutics companies. His work combines drug development expertise, services, and seed capital to help move companies from initial concept through Series A financing.
Experience
- Curie.BioCSO & co-foundercurrent2022 — presentanywhere you want it to be
- Cancer Research UK (CRUK)Board Member of Cancer Research Horizons and Therapeutic Innovationcurrent2023 — presentLondon Area, United Kingdom
- Johns Hopkins UniversityAdjunct Associate Professorcurrent2005 — presentBaltimore, MD
- Johns Hopkins UniversityPrincipal Investigator1994 — 2005Baltimore, MD
- Thrive, An Exact Sciences CompanyConsultant, R&D strategy2021 — 2022Cambridge, MA
- Thrive, An Exact Sciences CompanyChief Innovation Officer & co-founder2019 — 2021Cambridge, MA and Baltimore, MD
- Advise Connect Inspire (ACI)CEO & founder2017 — 2022Greater Boston
- Third Rock VenturesPartner2018 — 2022Boston, MA
- Third Rock VenturesVenture Partner2016 — 2018Boston, MA
- Blueprint MedicinesExecutive Vice President2016 — 2021Cambridge, MA
- Blueprint MedicinesCSO & Chief Drug Hunter2012 — 2016Cambridge, MA
- MOMA TherapeuticsCSO & co-founder2020 — 2021Cambridge, MA
- Celsius TherapeuticsCSO, president & co-founder2018 — 2020Cambridge, MA
- Creative Destruction LabAssociate2018 — 2019Greater Toronto Area, Canada
- German Accelerator Life SciencesCEO2015 — 2019Cambridge, MA
- SanofiGlobal Head of Oncology Drug Discovery and Preclinical Development2008 — 2012Paris Area, France & Cambridge, MA
- NovartisUnit Head - Oncology Drug Discovery2005 — 2008Cambridge, MA
Education
- The Johns Hopkins University - Carey Business SchoolMBA, Medical Services Management1997 — 2001
- The Johns Hopkins UniversityPostdoc, Molecular Biology1994 — 1996
- Research Institute of Molecular PathologyPostdoc, Molecular Biology1992 — 1994
- Heidelberg UniversityPhD, Biology1988 — 1992
- Universität SalzburgMagister, Human Genetics1985 — 1989
Skills & more
Entrepreneurship2Drug Discovery99Oncology12Life Sciences10Drug Development2Biotechnology
From Christoph's professional profile.
Same school
Also attended The Johns Hopkins University - Carey Business School17
Tony WellsVenture Partner at Copper Sky CapitalFloyd H. GriffithManaging Partner at Little Bristol PartnersMelissa GuttmanPrincipal, Talent at JMI EquityVipul KellaInvestor at FortySix Venture CapitalAndrew MausManaging Director, North America at AI CapitalMarissa MooreInvestor at OMERS Ventures
+ 11 more
Also attended The Johns Hopkins University206
Wes NicholsPartner at March Capital PartnersDemi ObayomiPrincipal at Sapphire VenturesCaitlinChief of Staff at Hummingbird VenturesJun JeonInvestor at Khosla VenturesNicole FraenkelInvestor at Khosla VenturesElena VibochManaging Director at General Catalyst
+ 200 more
Also attended Heidelberg University33
Mojca SkoberneEntrepreneur in Residence at GV (Google Ventures)Keita Yazakiシニア・アソシエイト (Senior Associate) at CyberAgent CapitalFabian HeilemannFounder & CEO at AENUStella PaffenholzSenior Associate at Atlas VentureKeith TanHead of DeFi at CaladanSteffen FunckInvestment Director at Statkraft Ventures
+ 27 more
Shared employers
Also worked at Cancer Research UK (CRUK)18
Giovanni MariggiInvestor at MedicxiDominic SchmidtGeneral Partner at Advent Life SciencesMilenko CicmilVenture Partner at Cure VenturesMartin TaylorPrincipal at F-Prime Capital PartnersAlex Badamchi-ZadehVice President at SV Health InvestorsSophie HughesInvestment Analyst at Seroba Life Sciences
+ 12 more
Also worked at Third Rock Ventures79
Lisa PurcellInvestor at Third Rock VenturesPaul MeloneInvestor at Third Rock VenturesLee VeneziaInvestor at Third Rock VenturesKevin MunnellyInvestor at Third Rock VenturesAmanda ChanInvestor at Third Rock VenturesJigar RaythathaInvestor at Third Rock Ventures
+ 73 more











































